The European Commission’s DG Joint Research Centre (JRC) has announced a new programme of work on colorectal cancer to be known as European Commission Initiative on Colorectal Cancer (ECICC) to be developed under the auspices of the Directorate General for Health and Food Safety (DG SANTE) and with the scientific and technical coordination of the JRC.
This new initiative will follow in the footsteps of the European Commission Initiative on Breast Cancer (ECIBC).
ECICC covers the whole colorectal cancer pathway, from screening through to end of life care via a voluntary European Quality Assurance scheme for all pathway care processes. The scheme will be based on evidence provided by updated European Guidelines, as well that developed within ECICC, and embedded in the EU legal framework for accreditation. ECICC work will be delivered in close collaboration with EuropaColon as well as with other stakeholders and participant countries.
For the overall ECICC, the first action will be to nominate the ECICC National Contacts via the Healthcare Attachés.
The ECICC will systematically incorporate all useful work, documents and surveys already performed in order not to ”reinvent the wheel”, while ex-novo developing what is needed and still unavailable
In particular, with regard to screening, a working group has already been established within the International Federation of Clinical Chemistry (IFCC) to investigate the potential to harmonize and improve Fecal Immunochemical Tests (FIT).
EuropaColon is delighted to be working with the JRC on this very important project!
EuropaColon is a European-wide platform for colorectal cancer (CRC) aiming to raise awareness, support patients, and campaign for equity of access to best treatment and care. 2017 plans include working with the EU Commission on standards of care for CRC patient pathways; re-energizing screening efforts with a dedicated Task Force, composed of countries with excellent screening rates; undertaking a Europe-wide survey of the Unmet Needs of Patients with mCRC. Work will also continue with our member groups to support their local policy and national initiatives, currently, with 43 Member Groups in 32 countries. EuropaColon has expanded its remit to other digestive cancers. Follow us on Twitter & Facebook